Panacea-ml
PrivateLast Round
Accelerator
Apr 30, 2024
Total Funding Raised
$200,000
Company Overview
Panacea-ml operates in Healthcare & Life Sciences and is based in Ra'anana. Its latest recorded funding round was an Accelerator round in April 2024.
Panacea-ml is a healthcare technology company that provides a machine learning-based SaaS platform to optimize and accelerate clinical trial outcomes for pharmaceutical companies and CROs.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Workflow Automation, Data Integration
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panacea-ml Comparables
Compare Panacea-ml with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flask Data | 79% | |
| Adaptive Clinical Systems | 77% | |
| Beaconcure | 76% |
For institutional investors. Book with your work email.
Panacea-ml Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Apr 30, 2024 | ||||
| Pre Seed | Nov 16, 2022 |
For institutional investors. Book with your work email.
Panacea-ml Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Pre Seed |
| PharmStars | Accelerator |
| Sanara Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
Monthly visitors grew 285% MoM, from 407 to 1.6K.
- Mar 1, 2026
Monthly visitors increased 189% MoM.
For institutional investors. Book with your work email.
Panacea-ml Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Panacea-ml's valuation, stock price, and market status.
Is Panacea-ml a public or private company?
Panacea-ml is a private company.
What is the current stock price of Panacea-ml?
Panacea-ml is a private company with no public stock price. Caplight tracks Panacea-ml's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Panacea-ml worth (valuation)?
Valuation information for Panacea-ml is not publicly available.
Can I buy Panacea-ml stock?
Panacea-ml shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Panacea-ml's last funding round?
Panacea-ml's most recent funding round was Accelerator on April 30, 2024.
Who are the main investors in Panacea-ml?
Key investors in Panacea-ml include Israel Innovation Authority, PharmStars, Sanara Ventures.
Will Panacea-ml IPO soon?
No public IPO plans have been announced for Panacea-ml.
How can I track Panacea-ml secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Panacea-ml's secondary market activity and sign up for updates.